Hospital-Acquired Pneumonia Developed in Non-Intensive Care Units

Basit Öğe Kaydı
dc.authorwosid, Osman/AGR-7980-2022
dc.authorwosid, osman/HRD-6024-2023
dc.contributor.authorEdis, Ebru Cakir
dc.contributor.authorHatipoglu, Osman N.
dc.contributor.authorYilmam, Ilker
dc.contributor.authorEker, Alper
dc.contributor.authorTansel, Ozlem
dc.contributor.authorSut, Necdet
dc.date.accessioned2024-06-12T11:09:16Z
dc.date.available2024-06-12T11:09:16Z
dc.date.issued2009
dc.departmentTrakya Üniversitesien_US
dc.description.abstractBackground: There are few studies about hospital-acquired pneumonia (HAP) developing in non-intensive care units (non-ICUs). Objectives: The aim of this study was to determine the incidence rate of non-ICU HAP, the risk factors associated with mortality and the survival rates of HAP patients at 6 weeks and 1 year. Patients and Methods: Between March 2005 and February 2006, 154 adult patients (97 males) with HAP were prospectively evaluated. Immunocompromised patients who were developing pneumonia were excluded from the study. The HAP incidence was calculated and survival was noted at 6 weeks and 1 year later. Kaplan-Meier methods were used for survival analysis; Cox regression was used to identify the risk factors associated with HAP-induced mortality. Results: During the study, and not counting those in the ICU, 45,679 adult patients were hospitalized. Of these, 154 patients developed HAP (incidence 3.3 cases/1,000 patients). The mean age of those developing HAP was 64.53 +/- 14.92 years (range 15-98). Survival rates at the 3rd, 7th, 14th, 42nd and 365th day were 91, 89, 69, 49 and 29%, respectively. Independent risk factors associated with 6-week mortality were: age [relative risk (RR) 1.026; 95% confidence interval (CI) 1.008-1.045], chronic renal failure RR 1.8; 95% CI 1.087-3.086), aspiration risk (RR 2.86; 95% CI 1.249-6.564), steroid use (RR 2.35; 95% CI 1.306-4.257), and multilobar infiltration (RR 2.1; 95% CI 1.102-4.113). Conclusion: HAP - even if it develops in non-ICU environments-is hard to treat and has a higher mortality rate. Copyright (C) 2009 S. Karger AG, Baselen_US
dc.identifier.doi10.1159/000232392
dc.identifier.endpage422en_US
dc.identifier.issn0025-7931
dc.identifier.issn1423-0356
dc.identifier.issue4en_US
dc.identifier.pmid19648731en_US
dc.identifier.scopus2-s2.0-70350347142en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage416en_US
dc.identifier.urihttps://doi.org/10.1159/000232392
dc.identifier.urihttps://hdl.handle.net/20.500.14551/22750
dc.identifier.volume78en_US
dc.identifier.wosWOS:000271024600011en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherKargeren_US
dc.relation.ispartofRespirationen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectNon-Intensive Care Uniten_US
dc.subjectHospital-Acquired Pneumoniaen_US
dc.subjectSurvival Analysisen_US
dc.subjectNosocomial Pneumoniaen_US
dc.subjectVentilator-Associated Pneumoniaen_US
dc.subjectNosocomial Pneumoniaen_US
dc.subjectRisk-Factorsen_US
dc.titleHospital-Acquired Pneumonia Developed in Non-Intensive Care Unitsen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu